Filter by: Subject

Filter by: Subject

Results Per Page:

Human immunodeficiency virus (HIV) (54)
South Africa (SA) (46)
SDG-03: Good health and well-being (28)
COVID-19 pandemic (24)
Coronavirus disease 2019 (COVID-19) (23)
Antiretroviral therapy (ART) (18)
Treatment (16)
Streptococcus pneumoniae (14)
Patients (13)
Pneumococcus (13)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (13)
Tuberculosis (TB) (13)
Neutrophils (12)
Mesenchymal stromal/stem cells (MSCs) (11)
Community-acquired pneumonia (CAP) (10)
Platelets (9)
Biomarkers (8)
Children (8)
Infection (8)
Inflammation (8)
Mortality (8)
Pneumolysin (8)
Reactive oxygen species (8)
HIV-1 (7)
South Africa (7)
Africa (6)
Cancer (6)
Cytokines (6)
Gene therapy (6)
Macrolides (6)
Mycobacterium tuberculosis (MTB) (6)
Chemotherapy (5)
Corticosteroids (5)
Ethics (5)
Immune activation (5)
Immunosuppression (5)
Immunotherapy (5)
In vitro (5)
Lung cancer (5)
Obesity (5)
Rheumatoid arthritis (RA) (5)
Smoking (5)
Acquired immune deficiency syndrome (AIDS) (4)
Adipose tissue (4)
Angiogenesis (4)
Antibiotics (4)
Breast cancer (4)
Calcium (4)
Cell therapy (4)
Community-acquired pneumonia (4)
Diagnosis (4)
Disease (4)
Drug resistance (4)
Growth (4)
Human leukocyte antigen (HLA) (4)
Hydrogen peroxide (4)
Immune checkpoint inhibitor (ICI) (4)
Immune checkpoint inhibitors (4)
Immune system (4)
Informed consent (4)
Luteinizing hormone (LH) (4)
Microbial translocation (4)
Nausea (4)
Nivolumab (4)
Pneumonia (4)
Toll-like receptors (4)
Vaccine (4)
Vasopressin (4)
Adipogenesis (3)
Antibiotic resistance (3)
Antiretroviral agents -- South Africa (3)
Antiretroviral treatment (ART) (3)
Autoantibodies (3)
C-reactive protein (3)
Cardiac complications (3)
Cell migration (3)
Cystic fibrosis (CF) (3)
Febrile neutropenia (3)
Follicle-stimulating hormone (FSH) (3)
Gene expression (3)